Loteprednol Etabonate for the Treatment of Dry Eye Disease

Volume: 36, Issue: 7, Pages: 497 - 511
Published: Sep 1, 2020
Abstract
Dry eye disease (DED) is a common ocular condition that can impair vision and may adversely impact quality of life. Due to the inflammatory nature of this disorder, topical corticosteroids are an effective treatment option, particularly for moderate-to-severe DED when first-line treatments, such as ocular lubricants, are insufficient. Loteprednol etabonate (LE) is a retrometabolically designed corticosteroid with a low propensity to cause...
Paper Details
Title
Loteprednol Etabonate for the Treatment of Dry Eye Disease
Published Date
Sep 1, 2020
Volume
36
Issue
7
Pages
497 - 511
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.